Connecting Oncology Evidence | Structured Research Intelligence | Global Research Scope
CS Cancer Solutions
Connecting oncology evidence.
Revealing the relationships that matter.
CS Cancer Solutions is a structured oncology research-intelligence and data-analytics platform connecting clinically and scientifically significant variables across the cancer research landscape.
We improve oncology research performance and evidence clarity through structured data intelligence.
The platform's public research and educational resources are available now; paid institutional research engagements are being developed through interviews and possible pilots.
Explore connected research. Compare reported findings. Identify evidence gaps.
Explore Six Core Areas of Oncology Intelligence
Discover specialists, cancer centers, clinical trials, biomarkers, rare cancer resources, and emerging oncology research through six interconnected intelligence areas.
Cancer Specialists
Find oncology specialists by specialty, cancer type, institution, and location.
Learn moreCancer Centers
Explore leading cancer hospitals, research centers, and comprehensive cancer programs.
Learn moreClinical Trials
Discover active and emerging oncology clinical trials.
Learn moreBiomarkers
Explore biomarkers, molecular targets, and precision oncology.
Learn moreRare Cancers
Access dedicated information for rare and underrepresented cancers.
Learn moreEmerging Research
Stay current with evolving oncology discoveries and evidence.
Learn moreFrom the Research Desk
Weekly Evidence Brief
A weekly selection of the most significant new oncology evidence worldwide connecting biomarkers, therapies, clinical trials, outcomes, and guidelines, with source-linked analysis of what changed and why it matters.
Latest Edition
Weekly Evidence Brief — October 9, 2026
Published October 9, 2026
3 evidence items
From Fragmented Evidence to Connected Intelligence
Cancer research information is abundant, but fragmented across disconnected databases, publications, trial registries, institutions, and research systems.
CS Cancer Solutions transforms fragmented oncology evidence into structured, connected intelligence so researchers and R&D organizations can:
- find relevant public evidence
- connect relationships across multiple research sources
- compare therapies, biomarkers, trials, institutions, investigators, and reported findings
- explore context from published, aggregate outcomes research
- identify evidence gaps, emerging signals, and uncertainties
- uncover overlooked research questions across the ecosystem
"What works? For whom? Under what conditions?
Where? With what outcomes? And what evidence supports it?"
A live example: the ocular (uveal) melanoma module lets visitors explore research context for this uncommon cancer type. It is currently the platform's only live rare-cancer module; similar modules for other cancer types are in development.
Explore the Ocular Melanoma Module →Core Intelligence Domains
CS Cancer Solutions organizes the global oncology evidence ecosystem into six structured intelligence domains.
Outcomes Intelligence
Structured visibility into published outcomes research, survival trends, treatment effectiveness, and evolving evidence across oncology domains.
Research Landscape Intelligence
Analysis of research activity, publication growth, emerging scientific domains, and changing evidence ecosystems across cancer research.
Clinical Trial Intelligence
Contextual organization of clinical trial activity, therapeutic development, study concentration, and research momentum across oncology.
Biomarker Intelligence
Visibility into biomarker-focused research, molecular targets, precision oncology trends, and evolving areas of scientific interest.
Rare Cancer Intelligence
Improved visibility into rare and underrepresented cancer research landscapes, evidence development, and emerging scientific activity.
Institutional Intelligence
Insights into institutional research participation, domain specialization, evidence contributions, and research positioning across oncology ecosystems.
"Transforming fragmented oncology evidence into actionable research intelligence."
The Missing Connective Layer in Oncology Analytics
CS Cancer Solutions is being developed to connect those layers.
Many existing platforms specialize in individual parts of the oncology evidence landscape — clinical trials, publications, genomic data, EHR data, treatment pathways, or isolated datasets.
Rather than analyzing oncology evidence in isolation, CS is designed to reveal relationships across the broader research ecosystem — organized around the six core intelligence domains shown above.
Navigate the Platform: Four Ways to Browse Oncology Evidence
Four starting points for browsing the public research resources on this platform — separate from the six core intelligence domains described above:
Built for Oncology R&D
Designed for Researchers • Cancer Centers • Healthcare Institutions • Biotech & Pharma • Life-Science Organizations • Research & Innovation Teams
Researchers
Find relevant public evidence and connect relationships across multiple research sources.
Cancer Centers
Explore research activity, clinical-trial ecosystems, and institutional research context.
Healthcare Institutions
Compare therapies, biomarkers, trials, institutions, investigators, and reported outcomes across oncology domains.
Biotech & Pharma
Explore where outcomes are reported in published research and under what conditions.
Life-Science Organizations
Uncover evidence gaps, emerging signals, and overlooked opportunities across the research ecosystem.
Research & Innovation Teams
Connect relationships across multiple research sources and explore institutional research context.
Find cancer types, specialists, clinical trials, and research articles
Searches cancer types, specialists, clinical trials, articles, and research updates
Built from Personal Experience
"After navigating fragmented oncology information while supporting my father through his battle with ocular melanoma, I realized cancer research shouldn't be scattered across disconnected sources. I created CS Cancer Solutions to transform fragmented evidence and research into a structured oncology intelligence platform."
— Suvi M. Bayly, Founder
Public Research Sources We Draw From
Source-Linked Oncology Research
Research and educational content is drawn from public sources including ClinicalTrials.gov, PubMed, the National Cancer Institute, and WHO. These organizations are independent of CS Cancer Solutions and do not endorse, sponsor, or affiliate with the platform.
ClinicalTrials.gov
US National Library of Medicine
PubMed
NCBI Research Database
National Cancer Institute
NCI (USA)
World Health Organization
WHO IARC
ESMO
European Society Medical Oncology
ASCO
American Society Clinical Oncology
EMA
European Medicines Agency
FDA Oncology
US Food & Drug Administration
Privacy by Scope
Not intended to receive patient information • Educational and research use
Privacy & Data Scope →Public-Source Cancer Research
Public-source research context • Educational and non-prescriptive • Original sources linked where available
Our Mission & Values →Source-Linked Research
Content drawn from public registries, literature, and public institutional sources • Links to original sources where available
View Research Updates →How Our Research Content Is Sourced
Public Sources
Research drawn from public registries and literature
Source Links
Links to original sources where available
Source Transparency
Original sources identified where available
Educational Use
Informational only, not medical advice
